Halozyme Therapeutics’s (HALO) 10-Day exponential moving average is 63.94, while Halozyme Therapeutics’s (HALO) share price is $64.49, making it a Buy.
Halozyme Therapeutics’s (HALO) 100-Day exponential moving average is 68.26, while Halozyme Therapeutics’s (HALO) share price is $64.49, making it a Sell.
Halozyme Therapeutics’s (HALO) stock price is $64.49 and Halozyme Therapeutics’s (HALO) 50-day simple moving average is 69.87, creating a Sell signal.
Halozyme Therapeutics’s (HALO) stock price is $64.49 and Halozyme Therapeutics’s (HALO) 100-day simple moving average is 69.30, creating a Sell signal.
Halozyme Therapeutics’s (HALO) stock price is $64.49 and Halozyme Therapeutics’s (HALO) 200-day simple moving average is 67.31, creating a Sell signal.